1. Home
  2. BNS vs BSX Comparison

BNS vs BSX Comparison

Compare BNS & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank Nova Scotia Halifax Pfd 3

BNS

Bank Nova Scotia Halifax Pfd 3

HOLD

Current Price

$80.69

Market Cap

98.1B

Sector

N/A

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$48.56

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNS
BSX
Founded
1832
1979
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.1B
93.4B
IPO Year
2024
2010

Fundamental Metrics

Financial Performance
Metric
BNS
BSX
Price
$80.69
$48.56
Analyst Decision
Hold
Strong Buy
Analyst Count
1
22
Target Price
$106.00
$93.18
AVG Volume (30 Days)
1.9M
21.1M
Earning Date
05-27-2026
04-22-2026
Dividend Yield
4.21%
N/A
EPS Growth
N/A
55.20
EPS
N/A
0.90
Revenue
N/A
$9,076,000,000.00
Revenue This Year
$26.54
$11.85
Revenue Next Year
$4.77
$10.16
P/E Ratio
$18.76
$54.16
Revenue Growth
N/A
12.49
52 Week Low
$53.72
$47.17
52 Week High
$82.22
$109.50

Technical Indicators

Market Signals
Indicator
BNS
BSX
Relative Strength Index (RSI) 60.29 31.34
Support Level $74.37 N/A
Resistance Level $82.22 $58.35
Average True Range (ATR) 1.33 1.59
MACD 0.02 -0.29
Stochastic Oscillator 69.77 11.24

Price Performance

Historical Comparison
BNS
BSX

About BNS Bank Nova Scotia Halifax Pfd 3

The Bank of Nova Scotia is a global financial services provider with over CAD 1.46 trillion in assets as of the end of fiscal 2025. The bank has four major business segments: Canadian banking, international banking, global wealth management, and global banking and markets. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in the Latin America region.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: